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ABSTRACT 
Background: Implants have been widely used in the medical field. It was adopted in 
dentistry, offering patients replacement of missing teeth. Researchers have been 
investigating techniques to improve implants’ survival. Among these techniques is plasma 
glow discharge. Radio-frequency Glow discharge (RGD) is a surface treatment and 
sterilization technique with the aim to improve the titanium oxide layer for better 
osseointegration. Previous studies have evaluated its effect on non-human cell lines with 
promising results. Up to date, there is no report on how RGD surface treatment of titanium 
affects normal human osteoblasts. 
 
Material and methods: Human bone fragments were obtained from dental extraction sites 
and were processed to culture normal human osteoblasts. Cells were seeded on three 
different surfaces at a concentration of 1x105 cells per plate; Titanium discs with and 
without Argon RGD (ARGD), and tissue culture plates (TCP). Dishes were allocated to 3 
timelines: 16 hours, 7 days and 14 days. The outcome measures were cell attachment, cell 
number, alkaline phosphatase and osteocalcin levels. 
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Results: Data was analyzed using a one-way ANOVA test. Mean cell proliferation 
percentage for the ARGD group at 7 days was the highest (167.966%). The difference in 
means among the three groups at 7 days was statistically significant (p=0.0022). At 14 
days, the highest mean of cell proliferation percentage was highest for the ARGD group. 
When testing all pairs, at 7 days the differences in means were statistically significant 
between (ARGD vs. no ARGD, and ARGD vs. TCP) (p=0.0018, and p=0.0286), 
respectively. At 14 days, the differences in means were statistically significant between 
(ARGD vs. TCP, p= 0.0003) and (no ARGD vs. TCP, p=0.0007). There was a significant 
difference in means for alkaline phosphatase and osteocalcin at 7 and 14 days between 
TCP and ARGD, and TCP and no ARGD groups (p < 0.05). 
 
Conclusions: The results of this study on normal human osteoblasts indicated that ARGD 
significantly enhanced cell proliferation. There was no significant difference in osteogenic 
behavior between with and without ARGD treatment on titanium surfaces within the time 
studied. A prolonged phase of cell proliferation was observed in ARGD treated groups. 
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1. Introduction and Background 
1.1. Dental implants: 
 Up until early last century, options to replace missing teeth have included removable or 
fixed prosthesis or no replacement at all. Nowadays, dental Implants became a vital 
treatment option offered to patients on a regular basis to replace missing teeth and is 
considered to be the gold standard [1]. These are metal fixtures that are surgically placed in 
the mandible and/or maxilla, with the attempt to achieve osseointegration with the patient’s 
own jawbone [2]. Once osseointegrated, dental implants serve as an anchor for dental 
prostheses and restorations which can be placed at a later time [3]. Compared to removable 
or fixed prosthesis, dental implants carry the advantage of having better longevity, 
esthetics and protecting neighboring virgin teeth [4, 5]. The reported total success rate of 
single-tooth implants has been as high as 98.8% at 10 years [6]. However, the success rate 
may change based on many factors including patients population, location, number and 
type of implants and many more. Other studies reported failure of dental implants to be as 
high as 10% of cases within a 5-year period for maxillary posterior implants specifically 
[7]. Dental researchers have spent most of their focus in the last decade on improving 
dental implants’ success rate and survival. A major determination of implant success 
includes the quality and quantity of implant-bone interface, which is part of the 
osseointegration process [8, 9]. Hence, enhancing osteoblasts’ attachment to implant 
surfaces would improve the success rate. In addition, improving factors like implants’ 
biomechanical features and properties, site preparation, provider skills and implant 
handling can lead to higher success rates.  
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1.2.  Implant biocompatibility and the implant-bone interface: 
 Since the beginning of implant dentistry era, researchers have been actively searching 
for the best implant material and design. Ideal dental implant design would provide 
resistance to bacterial contamination, achieve primary stability and facilitate rapid and 
sustainable osseointegration [10, 11]. In addition, the implant should not only be inert and 
biocompatible, but also be bioactive to elicit a desired cellular response such as protein 
adsorption, cell attachment, proliferation and differentiation to achieve osseointegration. 
Large amounts of any metal cannot be tolerated by the human body and thus minimizing 
the mechanical and chemical breakdown is a primary consideration when choosing an 
implant material [12].  
 
 Various metals and alloys have been evaluated in-vitro and clinically including titanium 
(Ti). Researchers concluded that dental materials, other than titanium, might corrode or 
wear generating particulate debris, which may elicit an unfavorable biological response at 
the surgical site [13]. On the other hand, Ti alloys have been demonstrated to be well 
tolerated by the human body because of their passive oxide layers while maintaining good 
biomechanical properties [14]. 
 
1.3.  Implant, titanium and oxide layer: 
 Implant biocompatibility with human tissue is key for success, which lack tissue 
rejection by human immune response. Other components include surface composition and 
structure, oxide layer thickness and surface contamination, which is governed by the 
implant sterilization process [15]. Ti in its natural state lacks bioactive potential to bond to 
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bone tissue, unless it forms an oxide layer spontaneously in air [16, 17]. Natural TiO2 
layers are thin (~3-8 nm) and amorphous, and less stable for favorable 
osseointegration.[18] Low dissolution rate and near chemical inertness allows bone to 
thrive and osseointegrate with Ti [19]. In-vitro and in-vivo studies have demonstrated 
better tissue response with alteration in surface oxide layer [20]. At the same time, Ti is 
known to have a high friction coefficient and the tendency to form adhesive joints and 
debris resulting in a long-term failure risk [21]. Both commercially pure titanium (CPTi), 
and its alloy titanium-aluminum-vanadium (Ti-6Al-4V) possess excellent corrosion 
resistance. In the recent years, Ti-6Al-4V has replaced CPTi due to higher mechanical 
strength in the medical and dental fields [22-24]. In addition, the surface oxide layer was 
noted to be enriched with aluminum-oxide in Ti-6Al-4V alloy compared to CPTi [19].  
 
 
1.4. Dental implants osseointegration: 
 Osseointegration (OI) is a biological process defined as a direct structural and functional 
bond between the mature jaw-bone osteotomy wall and dental implant surface with no cell 
barrier in between [25]. The OI process starts as soon as osteoprogenitor cells from the 
alveolar crest initiates the healing process of the osteotomy wall and neighboring 
periodontium [26]. This includes undifferentiated periodontal ligament fibroblasts, 
osteoblasts and cementoblasts [27, 28]. The healing process starts with progenitor cells 
adhesion to the implant surface, followed by proliferation and differentiation of 
osteoblastic cells [29]. Osteoblasts will produce a bone extra-cellular matrix (ECM) to 
create bone-to-implant contact [29]. ECM includes a wide range of proteins including 
fibronectin, and human bone sialoproteins or peptides which can bind to the implant oxide 
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layer to increase osteoblast adhesion [30]. This process is mediated by integrin receptors 
that recognize the tripeptide arginine-glycine-aspartic acid (AGA). Once achieved, this 
stable bone to implant contact can support a dental prosthesis and distribute force loads at 
and around the interface between bone and implant [31]. In addition, the risk of peri-
implantitis will be decreased.  
 
 Osseointegration is a major influencing factor in the success of dental implants. The role 
of titanium dental implant surface treatment, chemical or topographic modification, and 
cells interactions are important parameters that can affect bone healing, promote 
accelerated osteogenesis, increase bone-implant contact and bond strength [32]. At room 
temperature, Ti oxidizes upon exposure to oxygen forming a thin, stable and contiguous 
layer of TiO2. This process has been in industrial use to improve Ti properties and surface 
hardening via thermal rather than air oxidation. When the implant surface contacts 
biological tissue, mainly bone and blood, molecules of water initiates the first step of OI 
with surface wettability [33]. This phenomenon influences the TiO2 to modulate protein 
adsorption and osteoblast cell attachment [30]. Using Ti as a main implant alloy, 
osteoblasts create implant OI through adhesion and differentiation to Ti-surfaces through 
binding of extra-cellular matrix proteins containing AGA amino acid sequence via the 
integrin-mediated signaling cascade [34].  
 
 
1.5. Osteoblasts: 
 Osteoblasts are key players in bone healing and formation around dental implants, 
including the process of OI. These are mononucleate mesenchymal cells, with the potential 
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to differentiate into bone, cartilage and adipose tissue depending on the activated signaling 
pathway [35, 36]. In addition, they are responsible to create and maintain skeletal 
architecture and synthesis of the organic matrix of bone [35]. They can also influence the 
mineralization of bone matrix [37, 38]. Osteoblast growth and differentiation are controlled 
by several factors including a wide range of cytokines and growth factors [39].  
 
 When a dental implant is placed in the alveolar bone, osteoblasts are one of the very 
first cells to proliferate and differentiate laying down the matrix to form a new layer of 
bone. Osteoblasts are not only the key cells for OI, but rather function to maintain the 
dental implant following OI. Ossseointegrated implants are under continuous stresses due 
to function [31]. As a result, osteoblasts assist with bone remodeling through bone 
deposition [40]. 
 
 
1.6. Alkaline phosphatase and Osteocalcin: 
     At the initial healing phase of OI, bone alkaline phosphatase is activated, followed by 
osteocalcin synthesis and initiation of the mineralization process [41]. Alkaline 
phosphatase is an enzyme, surface protein associated with osteoblastic differentiation [42, 
43]. It has a prominent role in bone formation and mineralization processes [44]. The level 
of alkaline phosphatase expression increases during matrix synthesis by osteoblasts [45]. 
In addition, an increase in alkaline phosphatase level corresponds to more osteoblast 
differentiation [46]. Alkaline phosphatase is considered a reliable marker for osteoblast 
function. 
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 Osteocalcin is a non-collagenous protein expressed under 1.25-dihydroxyvitamin D and 
osteoblasts [47]. It is a protein that can only be found in bone, mineralized cartilage as well 
as teeth [48]. Osteocalcin is known to act as a chemotactic agent and initiates bone turn 
over via recruitment of osteoclasts [48]. The level of osteocalcin expression has been 
linked to the onset of bone mineralization, bone formation and correlates with bone 
turnover [48]. Osteocalcin is another marker for osteoblast function, which has been 
widely used before.  
 
1.7. Methods to improve dental implant success: 
 Improving Ti implants bioactivity, mainly in respect to human body cells, is the core of 
researchers interest. Most of the previous research work was dedicated to improve implant 
surface characteristics and treatment to be physically and biologically compatible with 
alveolar bone and to achieve rapid and efficient osseointegration.  
 
1.8. Implant surface modification: 
 Researchers have concluded that higher implant roughness; increased surface energy 
and surface hydroxyl groups will result in better and increased osteoblast activity and 
attachment. Surface grit blasting and polishing methods enhance cell growth, and improve 
implant fixation through increases in interlocking surface area and alterations of oxide 
thickness [49]. Ti-implant surface characteristics like implant topography, roughness and 
energy level have been shown to affect bone cells attachment and behavior [50, 51]. Older, 
and conventional dental implants contain micro rough surfaces, and smoothness at a nano-
level, which favors fibrous encapsulation, rather than bone osseointegration. To overcome 
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these limitations, and create Ti-implants with surface nano-roughness many researchers 
attempted to improve Ti mechanical properties, mainly through surface treatment.  
 
 
1.9. Implant surface treatment: 
 Implant surface treatment became a critical step to improve dental implants’ outcome. 
Various strategies and surface treatments have been studied to improve bone integration to 
titanium-based implants. Implant surface coating is among these options [52, 53]. 
Osteoconductive calcium phosphate (CaP) coating has been tested before [52-55]. This 
surface treatment can be applied by several methods including plasma spraying, 
electrochemical methods and biomimetic precipitation [54]. The rationale behind this 
treatment is to facilitate and attract osteoblasts to implant surfaces to initiate OI. However, 
human studies have shown coating dissolution of the implant surface shortly after 
implantation and was unable to function solely and had to be supported by other surface 
treatments. 
 
 Surface sterilization is a later manufacturing steps, where Ti implants go through one 
final surface preparation phase [56]. Common dental implant sterilization can be conducted 
via autoclave, radiation, dry heat treatment as well as glow discharge (GD) [57]. One 
implant surface treatment in particular had received more attention from dental researchers, 
which is plasma of Argon radiofrequency glow discharge (ARGD) treatment and it is the 
main focus of this research project. Several authors have demonstrated initial osteoblast-
like cell adhesion and activation of implant surface enhancing the osteoblast attachment on 
titanium, through physical treatment of the titanium implant surface with ARGD [58]. 
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Plasma of Argon treatment was demonstrated to have an advantageous effect on titanium 
surfaces including cleaning, corrosion protection and increasing surface energy of the 
cleaned surfaces [59].  
  
 
1.10. Glow discharge as a concept: 
 Plasma glow discharge is created by the passing of a low electrical current through a 
low-pressure gas by applying a voltage of at least 1 kV between two metal electrodes. This 
excites the gas molecules, resulting in a glow with colored light, which is used to treat the 
surface. Glow discharge is an implant surface treatment with the aim to modify and 
sterilize the fixture interface with bone. It can result in a unique phenomenon, which 
improves implant OI and success. Such treatment has shown to increase the oxide’s 
negative net charge, as well as increase in the number of osteoblasts’ attachment to surface 
via adsorbed fibronectin and an increase in the exposure of fibronectin-integrin binding 
domain for better osteoblast binding [60-62].  
 
 
1.11. The mechanism of glow discharge treatment: 
 Glow discharge has the ability to up-regulate multiple osteogenic proteins and enzymes, 
including fibronectin amplification which induces osteoblasts matrix protein changes upon 
adsorption [61]. In addition, it increases the expression of osteoblast genes and adsorbed 
osteogenic protein activity [62]. A recent study by Rapuano et al. demonstrated an increase 
in calcium phosphate mineral formation in MCET3 cultures incubated with Ti-6Al-4V 
alloy discs treated with both heat or radiofrequency glow discharge [63]. In addition, there 
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was an increase in osteopontin, bone sialoprotiens and osteocalcin expression for both 
cultures, suggesting an enchantment of implant osteoinductive properties [63].  
 
 
1.12. Characteristics and benefits of ARGD: 
  Surface preparation, surface Titanium oxide treatment and sterilization through GD can 
be done using different processes [64]. This includes heat or radiofrequency plasma of 
multiple gases including oxygen and Argon (ARGD) application [60]. Plasma of argon 
radio-frequency glow discharge (ARGD) was first introduced in 1992 by Wagner, advising 
for advanced surface modification technologies and discussed the application of ARGD in 
implant dentistry [65]. It was originally used as a method to clean and process various 
surfaces in the microelectrics industry and for sterilization in the biomedical field. Later, it 
evolved into a method of implant surface modification in attempt to enhance OI and 
increase surface energy as well as enhance cell attachment [66]. ARGD is a non-
destructive gas plasma technique with the concept to sterilize and modify dental implant 
surfaces at room temperature and atmospheric pressure [67-69]. In addition, it has been 
demonstrated that ARGD treatment is capable of increasing surface wettability to facilitate 
coating various ECM proteins (type I collagen and fibronectin) onto the surface for better 
biocompatibility [70, 71]. Via the radiofrequency approach, biofunctional amine groups 
can be established on the Ti-implant surface to serve as an attachment site for various 
proteins [72]. ARGD has the ability to increase Ti-implant surface energy and cell binding 
[66]. ARGD provides an alternative, and more efficient option for Ti surface hardening to 
thermal processing, which carries less appealing properties. ARGD is known to enhance 
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osteoblast-like cells adhesion and differentiation, and increase adhesion of cell binding 
proteins containing AGA sequence [34]. 
 
  Thermal oxidation of Ti has been tested before, with and without plasma treatment. 
The surface treatment of ARGD have shown a thicker, and harder layer formation of TiO2 
without changing the alloy core structure. Cell adhesion to Ti-implants treated with ARGD 
has been tested before, which showed favorable cell attachment using a mouse fibroblast 
cell line. Using rabbit osoteoblasts, ARGD demonstrated an increase in cell attachment to 
Ti-implant discs [51]. A study by Rapuano et al. demonstrated that Ti-6Al-4V alloy discs 
treated with ARGD accelerated the formation of initiation sites for hydroxyapatite (HA) 
crystals due to an increase in bone sialoprotien induction in MCET3 cell culture [63]. 
 
  In a prospective clinical study by Canullo et al. in 2012, titanium abutments were 
treated with ARGD in a plasma reactor. Immediately thereafter, the abutment was screwed 
at 30 N. Measurements of bone levels were recorded at baseline, 6 months and 18 months 
after abutment insertion [73]. The author noted no change in bone level measured on 
periapical radiographs (PA) between 6 and 18 months. The same group conducted a follow 
up study to evaluate implant marginal bone level with a longer follow up in a prospective 
randomized triple blinded controlled clinical trial. In that study, the radiographic marginal 
bone level changes around platform implant abutments that were cleaned with and without 
ARGD in patients with a history of periodontal disease and thin gingival biotype was 
evaluated. Standardized PA digital radiographs were obtained at times of crown insertion 
at 6 and 24 months following final restoration. Statistical differences in mean bone level 
changes were found to be between both groups at 6 and 24 months suggesting for better 
	   12	  
surface cleanliness and preserved marginal bone with abutments treated with ARGD [74]. 
The proposed underlying mechanism indicates favorable titanium implant surface bacterial 
decontamination resulting in less inflammation and bone loss. An additional triple blinded 
randomized controlled trial was conducted to compare marginal bone levels around 
implants’ abutments sterilized with either plasma of Argon (test group) or steam cleaning 
(control group) in periodontally healthy patients. Patients were followed for 2 years after 
cementing restorative components. Bone levels around implants were evaluated using PA 
radiographs and microbiological analysis of the surface. There was no implant failure or 
complications in either groups and no patient dropped out of the study. With regards to 
surface microbiological analysis, bacterial growth of Staphylococci species including 
aureus strains was observed in the control group only. Mean bone loss for the control 
group was statistically higher compared to the test group (p=0.018) [75]. A beagle dog 
study compared implants treated with ARGD for 30 days to washed untreated implants. 
ARGD treated implants had a statistically significant increase in bone area fraction 
occupancy (BAFO) percentages and bone deposition on implant surface measured 
histologically[76].  
 
  Another study compared the effect of ARGD pretreatment to no treatment of titanium 
alloy Ti6Al4V on osteoblast-like cell lines (MC3T3-E1). RGD pretreatment produced 
statistically significant increases in total soluble calcium content as well as mass Ca:P ratio 
at 1-2 weeks of cell culture using spectroscopic analysis of mineral content. In addition, 
there was a gradual increase up until 4 weeks of culture [63].  
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  Few researchers looked at the synergistic effect of ARGD combined with other agents. 
Multiple studies have investigated effects of titanium surface treatment using ARGD with 
fibronectin or other protein sequence pretreatment on osteoblast-like MC3T3 cell lines. 
These studies concluded that this combined surface treatment could result in an enhanced 
cell attachment, proliferation and differentiation [34].  
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2. Rationale and clinical significance for this research 
 
 Implant surface treatment with RGD has been suggested to increase implant success and 
survival as well as preserving the surrounding bone level. Previous studies evaluated the 
effect of RGD treated surfaces and noted to have a positive impact on cell proliferation. In 
addition, enhanced differentiation of cultured mouse osteoclast cells on titanium surface 
was noted with RGD [77]. Most of these studies used mouse pre-osteoblastic cells 
(MC3T3) as the cell line of interest to evaluate cellular behavior on RGD-treated surfaces. 
These are newborn Mus musculus mouse calvaria-derived cell lines which exhibits an 
osteoblastic phenotype and expresses alkaline phosphatase, osteocalcin and type I collagen 
[78]. However, it has been demonstrated that morphological and functional differences 
exist between bone cells derived from human and rodents’ calvaria [79, 80]. As a result, 
the use of non-human cell lines may impose certain limitations on the clinical application 
of all research conducted.  Additionally, the MC3T3-E1 cell line is phenotypically 
heterogenous, with subclones exhibiting high or low differentiation capacity making it not 
reliable to use for in-vitro studies. 
 
 Surface treatment of Ti-dental implants with RGD could improve implant outcome and 
survival based on previous studies. However, up to date, there is no report in the literature 
describing the effect of RGD treated surfaces on normal human osteoblast cell attachment, 
proliferation and differentiation. Investigating and validating the RGD effects on human 
cells will help to confirm previous results, and facilitate the transition into clinical studies. 
In addition, this study could be used as a reference point to better understand the 
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mechanism by which RGD affects osteoblasts grown on titanium and its potential benefit 
in improving dental implants success and survival. 
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3. Hypothesis 
 
It is hypothesized that surface treatment of smooth pure titanium with radiofrequency 
plasma of Argon glow discharge would enhance cell attachment, proliferation and 
osteogenic activity, specifically cell differentiation, of normal human osteoblasts. 
 
The null hypothesis (H0) is that there is no difference in cell attachment, proliferation and 
osteogenic differentiation among the three experimental surfaces; titanium with ARGD 
treatment, titanium without ARGD treatment, and standard tissue culture plates. 
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4. Specific Aims 
Aim 1: To measure cellular attachment of pre-osteoblasts on smooth titanium surfaces 
treated with ARGD, and compare it to cell attachment on non-treated titanium and standard 
tissue culture plates. 
 
Aim 2: To measure cellular proliferation rates at two different time points (7 and 14 days) 
on the three different surfaces, titanium treated and non-treated with ARGD and standard 
tissue culture plates. 
 
Aim 3: To measure the osteogenic activity and differentiation potential of human 
osteoblasts cultured on the three different surfaces. This will be achieved by: 
a) Measuring the tissue non-specific alkaline phosphatase activity in the collected 
supernatants from cell cultures collected from the different groups at 7 and 14 days. 
b) Measuring the osteocalcin levels expressed in the collected supernatants from cell 
cultures collected from the different groups at 7 and 14 days. 
 
Aim 4: To evaluate the change in titanium surface wettability, following treatment with 
ARGD. This will be achieved by comparing the contact angle measurement of a sessile 
distilled water droplet placed on titanium discs treated and not treated by ARGD. 
 
Aim 5: To evaluate morphological changes of the cultured cells attached on the different 
surfaces: titanium treated and non-treated with ARGD and standard tissue culture plates, 
using SEM imaging. 
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MATERIAL AND METHODS 
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5. Material and Methods 
• Table 1: List of materials: 
Material	   Manufacturer	   Catalog number	  
10 mL pipettes	   Fisher Scientific	   13-678-11E	  
2 mL pipettes	   Fisher Scientific	   13-678-11C	  
15 mL centrifuge tubes	   Fisher Scientific	   14-959-70C	  
1.5 mL tubes	   Fisher Scientific	   05-408-129	  
25 mL pipettes	   Fisher Scientific	   13-675-11	  
3x3 weighing paper	   Fisher Scientific	   NC9691607	  
50 mL centrifugation 
tubes	   Fisher Scientific 14-432-22 
60 mm Tissue culture 
Petri dishes with grip 
ring, sterilized by Gamma 
Irradiation	  
CELLTREAT Scientific 
products	   229660	  
Aspirating pipettes	   Fisher Scientific	   13-675-16	  
Corning 12.5 cm2 tissue 
culture flasks	   Fisher Scientific	   08-772-1F	  
Corning 225 cm2 tissue 
culture flasks	   Fisher Scientific	   1482680	  
Disposable masks	   Kimberly-Clark	   12978	  
Gloves	   Fisher Scientific	   19-130-1597	  
Manual pipette P100	   Gilson, Pipetman	   FA10004P	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Manual pipette P1000	   Gilson, Pipetman	   FA10006P	  
Manual pipette P20	   Gilson, Pipetman	   FA10003P	  
Manual pipette P200	   Gilson, Pipetman	   FA10005P	  
Multi tip pipette 
Transferpette 20-100 µL  
Brinkman	   10N3297	  
Multi tip pipette 
Transferpette 50-200 µL  
Brinkman	   07R2380	  
Pipette tips (blue), 200-
1000 µL	   Fisher Scientific	   21-278-52	  
Pipette tips (yellow), 1-
200 µL	   ENE Mate	   1031-800-010	  
Pro-pette pipette aid 
(pipette controller)	   MTC Bio	   P6080	  
Scalpel handles	   Patterson Dental	   089-4501	  
Semimicro cuvette	   Fisher Scientific	   14955127	  
Surgical Blades #11	   HENRY SCHEIN	   100-5794	  
Thermanox Plastic 
Coverslips, Cell Culture 
treated on one side, 
15mm diameter	  
NUNC	   174969	  
Weighing dish (medium)	   Fisher Scientific	   02-202-101	  
Weighing dish (small)	   Fisher Scientific	   02-202-100	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• Table 2: List of chemicals, enzymes, growth media and kits 
Item Manufacturer Model number 
0.05% Trypsin-EDTA	  	   Life Technologies	  	   25300054	  
10% Formalin	  	   Fisher Scientific	  	   HT501128-4L	  
1X DPBS	  	   Life Technologies	  	   14190-144	  
70% Ethanol	  	   Fisher Scientific	  	   S25306A	  
Alkaline phosphatase 
assay kit (colorimetric)	  	   Abcam	  	   ab83369	  
Beta Glycerophosphate Sigma G9422 
Calcium Chloride	  	   Sigma	  	   C-3306	  
Charcoal stripped FBS	  	   Life Technologies	  	   12676011	  
Chondroitin sulfate	  	   Sigma	  	   C-4384	  
Collagenase Type I	  	   Life Technologies	  	   17100-0	  
Crystal Violet, reagent	  	   Sigma	  	   229288-100G	  
DMEM/F12 (500mL)  Life Technologies  11330057	  
Elastase Type I	  	   Sigma Aldrich	  	   E125-50MG	  
Fetal bovine serum	  	   Life Technologies	  	   16000044	  
Fungizone (antifungal)	  	   Life Technologies	  	   15290-026	  
Glutaraldehyde	  	   Electron Microscopy 
Sciences	  	   16220	  
Hexamethyldisilazane 
(HMDS) 
Hyclone Trypan Blue solution	  	  
Sigma 
 
Thermo Scientific	  	  
H4875-500ML 
 
SV30084.01	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Hylcone L-Glutamine	  	   Fisher Scientific	  	   SH3003401	  
L-ascorbic acid 25g	  	   Sigma Aldrich	  	   A4544-25G	  
Magnesium Chloride 
Anhydrous	  	   Sigma	  	   BP214-500	  
Menadione 25g	  	   Sigma Aldrich	  	   M5625-25G	  
Osmium tetroxide 4% 
Aqueous solution 
Electron Microscopy 
Sciences 
19150 
Osteocalcin ELISA kit	  	   R&D Technologies	  	   DSTCNO	  
Pen/Strep 100X	  	   Life Technologies	  	   15140-122	  
Potassium Chloride	  	   Sigma	  	   P9541-500g	  
Sodium bicarbonate	  	   Sigma	  	   S5761-500G	  
Sodium Chloride	  	   Sigma	  	   BP358-212	  
Sodium Phosphate	  	   Sigma	  	   BP332-500	  
Triton X-100	  	   Sigma	  	   T-8787 
Vitamin D3	  	   Sigma	  	   1530-10UG	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• Table 3: List of equipment used: 
Item Manufacturer Model number 
360 stirrer VWR Scientific 58935-351 
Biological Safety Cabinet LABCONCO 3430809 
Centrifuge Marathon 
16KM 
Fisher Scientific 16KM 
Incubator Thermo ELECTRON 
CORPORATION 
3110 
Isotemp Waterbath  Fisher Scientific 10L-M 
Light microscope Leica LEITZ DM IL Type: 090-131.002 
Microplate reader 
(spectrophotometer) 
TECAN Infinite 200 Pro 
PH meter with electrode CORNING 320 
Roto Mix shaker Thermolyne M51335 
Scale DENVER 
INSTRUMENT 
P-314 
Scale OHAUS 3113 
SEM microscope HITACHI SU6600 
Spectrophotometer SPECTRONIC 20 
GENESIS 
4001/4 
Stirrer CORNING PC-320 
Table Top Centrifuge BECKMAN 340508 
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Tissue culture Hood, 
Class II A/B3 Biological 
Safety Cabinet 
 
Logic 
 
1184 
Touch mixer (tube shaker) Fisher Scientific 231 
Ultrasonic cleaner Fisher Scientific FS9 
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5.1. Approvals and training: 
      This study was approved by the Institutional Biosafety committee at Boston University 
(IBC approval 13-046). All necessary human subject trainings were completed through the 
Collaborative Institutional Training Initiative (CITI), as well as online trainings provided 
through the office of research at Boston University. An Exemption from the Institutional 
Review Board (IRB) to use biological waste material of human bone fragments, which 
cannot identify human subjects, was obtained (IRB# H-33173).  
 
5.2. Material: 
5.2.1. Agents and cells: 
Pre-osteoblast cells 
       The steps to obtain human pre-osteoblast cells was based on a previously published 
protocol.[80] Tissue culture isolation and maintenance were performed entirely under the 
class II biological lab safety hood to ensure sterile conditions. Human intra-oral bone 
fragments were obtained through the oral surgery department at Boston University School 
of Dental Medicine. Bone samples were obtained from discarded tissue during dental teeth 
extraction and other ostectomy procedures. Bone samples were collected and stored in a 
sterile tube containing 1X phosphate buffered saline (PBS) solution and transported to our 
lab in an icebox container holding the tubes for processing within one hour.  First, using a 
sterile surgical blade, soft tissue attached to bone was excised and scraped off. Bone 
fragments had a length ranging from 0.5 to 0.8 cm. Using a sterile micro dissecting scissor 
and #11 surgical blade, bone fragments were cut into 2-5 mm long pieces. Specimens 
utilized for our experiments were obtained from healthy patients between the ages of 18 
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and 50 years old whom have no systemic or metabolic bone diseases or acute infections, 
and did not use steroids in the last 6 months before surgery. Bone tissue was treated with 
an enzyme cocktail in a 1X Kreb’s solution. The enzyme cocktail is a mixture of 
Collagenase I (to separate fibroblasts and other cell lines) at a concentration of 3mg/mL, 
Elastase Type I at a concentration of 6.25 U/mL, Chondroitin sulfate 6 mg/mL, D-Sorbitol 
18.22 mg/mL and Penicillin 100 U/mL. The Kreb’s solution was prepared by dissolving; 
126 mM NaCl, 2.5 mM KCl, 25 mM NaHCO3, 1.2 mM NaH2PO4, 1.2 mM MgCl2, and 2.5 
mM CaCl2 in distilled water and adjusting the pH to (7.2). Then, the solution was sterile 
filtered. The bone fragments in the enzyme cocktail solution were then incubated in a 
water bath at 37°C twice, each time for 20 min. The enzymatic reaction was then blocked 
by adding 5 mL of the culture media [(10% fetal bovine serum FBS, 1X 
Penicillin/Streptomycin in DMEM/F12 (1:1)]. Then, media was removed after 5 minutes 
of centrifugation with 1000 rpm at room temperature (RT). The fragments of bone were 
washed with 1X PBS, which was then aspirated after centrifugation for 5 minutes with 
1000 rpm at RT. After enzymatic digestion of soft tissue and fibroblasts, bone fragments 
were cultured in a 12.5 cm2 flask containing 6 mL nutrient supplemented media of phenol 
red free Dulbecco’s Modified Eagle Medium (DMEM) with 10% fetal bovine serum for 
nutrition, 1X Penicillin/Streptomycin antibiotic (100 U/mL) and 1000x Amphotericin B 
anti-fungal (1:1), to prevent microbial contamination. The bone fragments were maintained 
at 37°C, in a standard CO2 incubator (5% carbon dioxide, and saturated humidity). Primary 
cell culture in the size 12.5 cm2 flask was allowed for 3-4 weeks until cells reached about 
70-80% confluence. (Figure 1) Growth media was changed every day for a total of 10 
days, followed by changing it every 72 hours thereafter. The process of media change was 
as follows; first the old media is aspirated, then 10 mL of 1X PBS is added to rinse the 
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surface of the flask and aspirated it, lastly 6 mL of new growth media is added. Bone 
fragments were kept in the flask for the first 7-10 days to allow cell migration from the 
bone and attaching to the flask surface. After that time, bone fragments were aspirated and 
discarded to allow the attached cells to grow freely on the flask surface and reduce the risk 
of microbial contamination. Isolation of pre-osteoblasts has been performed three times 
with bone fragments from three different patients and each experiment entirely has been 
performed three times, where for each experiment cells from the same patient was used for 
seeding onto the different surfaces of each group. 
 
5.2.2. Tissue culture maintenance and expansion: 
       When cells reached a 70-80% confluence, media was aspirated, followed by rinsing 
with 1X PBS then aspirating it. Then, using 1 mL of 0.05% Trypsin EDTA for 2-3 minutes 
at 37°C, the attached cells in the flask were trypsinized in order to transfer to a 225 cm2 
flask for the secondary cell culture. After checking for cell detachment from the flask 
surface using the light microscope, the reaction of the trypsin was blocked by adding 10 
mL of DMEM/F12 media. Cells re-suspended in the media were then aspirated and 
collected in a sterile 15 mL disposable tube for centrifugation for 5 minutes with 1000 rpm 
at RT. A pellet of cells in the bottom of the tube was evident after centrifugation, and the 
solution above the pellet containing the trypsin was carefully aspirated, and fresh media 
was replaced instead. The media with cells was then transferred, after re-suspension in the 
tube, using a pipette to be cultured in the 225 cm2 flask with 75-80 mL of growth media. 
This secondary cell culture took about 2-3 weeks to reach a 70-80% confluence. Same as 
for primary cell culture, the growth media was changed every day for the first 10 days, and 
then was changed every 72 hours. (Figure 2) 
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Figure 1. Photograph taken through the light microscope at (40x magnification) showing pre-
osteobalsts in cell culture reaching 70-80% cell confluence. 
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Figure 2. Primary and secondary cell culture.
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5.2.3. Determination of the optimal cell seeding concentration: 
       A pilot study was done to determine the optimum seeding concentration for our 
experiment in order to reach cell confluence at 7 days. This was achieved through testing 
multiple seeding cell concentrations on 60 mm culture plates: 5x105, 3x105, 1x105, 
0.5x105, 1x104, 3x104, 5x103 and 1x103. Densities of the cells were monitored daily using 
a light microscope and recorded. It was then determined that the optimal seeding 
concentration to reach confluence by 7 days is 1x105 cells. 
 
 
5.2.4. Titanium discs: 
       A total of 34 smooth titanium discs, 60 mm in diameter, and 0.5 mm thick, specially 
designed and obtained from University of British Columbia, Canada. These were 50 nm 
coatings of commercially pure titanium on silicon wafer discs achieved through 
evaporative deposition. They were made with 2 degrees taper to ensure maximum contact 
with the bottom of the Petri dishes for culture. Titanium discs were prepared by cleaning 
them in an ultrasonic unit ten times, while placed on a plastic rack holder, each disc being 
separated from the next by 3mm, using only distilled water for 30 minutes. The plastic 
holder was then removed after sonication and placed under the biological safety cabinet to 
dry. Seventeen of the titanium discs were then treated by plasma of Argon glow discharge, 
using a glow discharge machine, then placed into 60 mm diameter labeled Petri dishes 
marking the timeline and condition (GD). The glow discharge apparatus was assembled in 
our lab and consists of a plastic desiccator chamber, two circular aluminum electrodes (10 
cm in diameter) which are fixed in the chamber. The electrodes are perpendicular to the 
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long axis and are separated from each other by a distance of 4 cm. Each titanium disc was 
placed on the bottom electrode to be treated. The chamber was then closed and evacuated 
of any air using a vacuum pump (precision Scientific Co, India) through a controlled 
needle valve. A constant flow of Argon gas was allowed into the chamber via a second 
valve for 30 seconds. Then a high frequency voltage (Electro-Technic Products INC., 
Chicago, IL) of 1 kilo Volt (kV) was applied between the two electrodes for 4 minutes and 
a stable purple colored plasma was generated. (Figure 3)   
The remaining 17 discs were placed after drying into the labeled petri dishes  (-GD). The 
Human pre-osteoblast cells were then seeded on the three different surfaces at a 
concentration of 1x105 cells per disc: 
 1) smooth pure titanium coated silicon wafers treated with plasma of Argon glow 
discharge, 
 2) smooth pure titanium coated silicon wafers not treated with plasma of Argon glow 
discharge,  
3) standard tissue culture treated polystyrene petri dishes. (Figure 4) 
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Figure 3. Glow discharge machine connected to a high frequency voltage generator. The 
violet color in the chamber is the plasma of Argon generated by glow discharge. 
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Figure 4. Study discs and plates A) Titanium discs used to culture cells on, B) tissue 
culture plates used to culture cells on.
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5.2.5. Crystal Violet dye: 
       A toxic staining material known as “methyl violet” and has histological applications 
for staining bacteria, as well as staining cells to determine attachment to various surfaces 
was used in this study. This dye stains the cell’s DNA, and depending on the solubilization 
of the amount of dye taken up by the monolayer of cells attached on a surface, a relative 
density is quantified using a spectrophotometer machine. The dye is prepared by dissolving 
at a concentration of 0.2% (w/v). (0.2 g crystal violet dissolved in 100 mL deionized 
water). 
 
5.2.6. Alkaline phosphatase assay:  
     Alkaline phosphatase assay kit (Colorimetric) was purchased from Abcam to measure 
alkaline phosphatase activity in our biological samples (cell culture supernatants). 
 
 
5.2.7. Osteocalcin ELISA: 
      Human Osteocalcin Immunoassay (Quantikine ELISA) was purchased from R&D to 
measure human osteocalcin levels in cell culture supernatants. A monoclonal antibody that 
is specific for human osteocalcin is pre-coated onto a 96 well microplate provided in this 
kit and was used for our experiment. Samples and standards were pipetted into the wells of 
the microplate. Any present osteocalcin would bind to the antibody. Intensity of the color 
reflects the amount of osteocalcin present in the samples and is measured using a 
microplate reader.  
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5.3. Experiments: 
5.3.1. Evaluating the change in titanium surface wettability and contact 
angle following treatment with GD through the distilled water droplet 
experiment: 
        Same protocol was followed for cleaning the titanium discs using the ultrasonic unit 
as performed prior to cell culture. 
Using a dropper, a droplet of distilled water was added onto titanium discs surfaces treated 
and non-treated with ARGD, and horizontal images were taken using a Canon digital 
camera (REBEL T2i, USA). Contact angle was measured using a protractor to assess the 
degree of wettability after treatment of discs with ARGD compared to non-treated discs. 
 
5.3.2. Measurements of pre-osteoblast attachment: 
  This experiment was conducted to measure the efficiency of pre-osteoblast attachment 
on titanium discs treated with ARGD compared to control (non-treated titanium discs and 
plastic).  After conducting the pilot study to determine the optimum seeding concentration 
for our experiment in order to reach cell confluence at 7 days, it was then determined that 
the optimal seeing concentration for our experiment is 1x105 cells. To measure attachment 
efficiency of our cell line, we cultured the cells as described previously. The second 
passage cells at 70-80% confluence from the 225 cm2 flask was measured using a 
hemocytometer after trypsinizing the cells to detach from the flask surface. We counted the 
total number of cells from the flask, which on average ranged between 1.48x107 – 1.62x107 
cells. We labeled 6 Petri dishes with the timelines of interest to measure, and seeded 1x105 
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cells on each culture plate all at the same time. At different time intervals of 1 hour, 3 
hours, 6 hours, 9 hours, 12 hours and 16 hours, 1.5 mL of supernatant from each plate was 
collected in disposable tubes. These supernatants contained floating non-attached cells, that 
we then stained with (0.4%) trypan blue dye to test cell viability. Then, 100 µL from each 
tube was added to the Rechert-Jung hemocytometer and the number of living cells counted 
on the grid was recorded. The number of cells counted was subtracted from that originally 
seeded cell number (1x105) and the calculated number was converted the number to a 
percentage by dividing the two numbers and multiplying by 100. This gives us the 
estimated number of cells attached, considering 1x105 has 100% attachment efficiency. 
Based on that, the relative attachment efficiency at the different time intervals was easy to 
determine. Also, the cellular attachment efficiency of cell on the three different surfaces 
used in our study was tested (Ti with and without ARGD treatment and TCP), each surface 
condition in triplicate plates for each surface at 16 hours. 
 
 
5.3.3. Proliferation studies: 
       Proliferation studies were done using the crystal violet dye technique. Osteoblast cells 
at a seeding concentration of 1x105 for each group (Ti with GD, Ti without GD, and TCP) 
were cultured in plates with supplemented media and incubated for 16 hours, 7 days and 
14 days. Media was changed daily. At 16 hours, media was aspirated from all the labeled 
16 hour plates of all groups. Plastic Petri dishes and Titanium discs in their housing Petri 
dishes used for this study were all rinsed twice with 1X PBS and then fixed with 10% 
neutral buffered formalin for one hour at RT under the chemical safety hood. 
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     The formalin solution was then aspirated and discarded and all plates and discs were 
washed twice with deionized water for 5 minutes each time. Cells in each group were 
stained with 1 mL 0.2% (w/v) crystal violet solution for 30 minutes at RT. Unbound stain 
was removed by rinsing plates thoroughly with deionized water until clear. After that, 
exactly (900 µL) of Triton-X 1% (v/v) was added to each fully stained plate and placed on 
a shaker with 150 rpm for 10 minutes at RT. Saturated stain was removed with a pipette 
and collected in 1.5 mL labeled disposable test tube. An additional volume (300 µL) of 
Triton-X 1% was added to the partially stained plates, to complete the process of de-
staining by placing once again on the shaker with 150 rpm for 10 minutes at RT. A total of 
1.2 mL of solution containing the entire volume was collected from both steps. The plates 
were inspected and at that point were colorless. 
 
      In order to detect and record the optical density of the crystal violet in the Triton-X 
solution collected, 1 mL of the solution was pipetted from the tube containing the entire 
volume from both washes into a spectrometer cuvette. Next, the spectrophotometer 
apparatus (SPECTRONIC 20 GENESIS) was turned on and allowed 30 minutes to warm 
up and wavelength was set at 590 nm to detect the optical density value of cell-bound 
crystal violet. Initially, the spectrophotometer was calibrated to zero absorbency for the 
plain Triton-X solution of 1 mL volume. 
 
      The number of attached osteoblasts was obtained by quantifying optical density of 
crystal violet dye from a curve obtained by plotting cell number against optical density that 
we measured using the spectrophotometer. This was achieved by calculating the mean 
number of cells attached on the surface of each group using a hemocytometer after 
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trypsinizing the plate to detach the cells. Then, from a duplicate plate each matching the 
group measured, the crystal violet dye technique after cell fixation was used to obtain the 
optical density reading for the mean number of cells calculated from that plate at each 
timeline (16 hours, 7 days and 14 days). With knowing the mean cell number and optical 
density reading for the total number of cells seeded 1x105, calculations were made to 
obtain the percentage of cells proliferating and cell number increase at 7 and 14 days 
timelines for titanium groups compared to the control plastic group that was measured at 
each corresponding timeline. 
 
 
5.3.4. Tissue culture treatment for differentiation studies: 
      Three days before the supernatant was to be collected for differentiation studies from 
the 7 and 14 plates of all groups, the growth media was aspirated from all plates and then 
were washed twice with 1X PBS. Cells were cultured with pre-differentiation media 
consisting of 10% charcoal stripped FBS, 1% (v/v) Penicillin/Streptomycin antibiotic 
(1:100), 10-8 M Menadione, 10 mM β-Glycerophosphate, 1.5 mg/mL L-ascorbic acid, 
2mM L-Glutamine in plain DMEM/F12 media (1:1). 
 
      Two days before collection of the supernatant (corresponding to 24 hours exposure to 
pre-differentiation media), the media was aspirated and plates were washed with 1X PBS. 
Then, 3 mL of fresh differentiation media consisting of the same ingredients as the pre-
differentiation media, with the addition of 10nM Vitamin D3 (1:100) was added to all 
plates. 
	   42	  
Two days later, the supernatants from each plate were collected, divided in multiple tubes, 
and immediately frozen at -20°C.  
 
    The three-day differentiation process has been applied at two time intervals:  from day 4 
to day 7 and from day 11 to day 14. Supernatants were collected only at day 7 and day 14 
correspondingly and were analyzed as described in the next sections for alkaline 
phosphatase activity and for osteocalcin expression measurements. The corresponding 
plates were fixed and crystal violet stained to determine the cell number.     
 
 
5.3.5. Measurements of osteogenic expression by measuring alkaline 
phosphatase (ALP) activity in samples: 
        A total of 18 labeled plates based on each group and timeline of 7 and 14 days with 
osteoblasts cultured during our study were used for this experiment. At days 5 and 6 of cell 
culturing for the 7 days plates for all groups, the growth media was aspirated and replaced 
with differentiation media that was prepared in the lab according to protocol. This was also 
done on days 12 and 13 for the 14 days plates of all groups. The differentiation media 
consisted of 10% charcoal stripped FBS, Penicillin/streptomycin antibiotic 1:100 (v/v), 
Menadione (vitamin K) of 10-8 M, β-Glycerophosphate 10 mM, 1.5 mg/mL L-ascorbic 
acid, L-glutamine of 2 mM, and 600 µL of Vitamin D3 giving an end concentration of 
10nM (1:100), all in a calculated volume of F12/DMEM plain media. At day 7, all 
supernatants from all plates were collected in labeled sterile test tubes according to each 
condition and group. The same was done for the day 14 plates on the 14th day of cell 
culture, having being exposed to the differentiation media on days 12 and 13. The alkaline 
	   43	  
phosphatase (Colorimetric, Abcam) kit was used to measure the non-tissue specific 
alkaline phosphatase activity within supernatant samples. This kit utilizes an ALP reagent 
p-nitrophenyl phosphate (pNPP) as a phosphatase substrate, which turns yellow (λmax= 405 
nm) when dephosphorylated by ALP. Triplicate wells of differentiation media was used as 
the background, following manufacturer’s instructions.  
 
     Using a clear flat bottom 96 standard well plate for the assay, samples and standard 
solutions were all placed in triplicate wells in the plate. 20 µL of stop solution was added 
as an initial step to terminate any reaction in the wells containing the background. Then, 2 
tablets of pNPP were dissolved into 5.4 mL Assay Buffer to make 5 mM of work solution. 
For standard curve preparation, 40 µL of the 5 mM pNPP solution was diluted with 160 µL 
assay Buffer to generate 1 mM pNPP standard. By adding 0, 4, 8, 12, 16, 20 µL of the 
1mM pNPP standard prepared into the 96-well plate in triplicates, standards were 
generated for 0, 4, 8, 12, 16, 20 nmol/well pNPP standard by bringing the final volume 120 
µL with assay buffer. 
 
      Total volume for each sample well was brought to 120 µL according to manufacturer’s 
protocol. A volume of 40 µL from each sample collected in the test tube labeled with the 
condition/group and timeline, was pipetted into its corresponding well in triplicates based 
on a template we had formatted. 50 µL of 5mM pNPP solution was added to all sample and 
background wells. Then, 10 µL of ALP enzyme solution was added to standard wells. We 
covered the plate with a clear plastic film and placed it on an orbital shaker, and incubated 
the reaction at 25°C protected from light by covering with aluminum foil for 60 minutes. 
After the 60 minute incubation, 20 µL of stop solution was added to all wells except the 
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background wells, as it has been added initially, in order to stop the reaction. Finally, using 
a microplate reader, all wells were measured for OD readings at a wavelength of 405 nm 
according to the manufacturer’s protocol.  
 
     Mean absorbance measurement from background control was subtracted from all 
samples readings. Mean absorbance reading of the 0 nmol standard was subtracted from 
the other standard readings for the corrected absorbance. The corrected absorbance 
measurements were then plotted as values of a final concentration of pNPP. The best-fit 
line that passes through the points was drawn through Excel software and a trendline 
equation based on our standard curve was calculated. Using the equation generated from 
the standard curve, the amount of pNPP in all test samples of all groups was measured  (y= 
80.931x -0.02 with an R2 of 0.99389) by converting absorbance readings to alkaline 
phosphatase activity in µmol units. 
 
      Based on the formula provided in the kit, µmol units of pNPP divided by the sample 
volume (0.001 mL) and divided by the reaction time (60 mins) allowed us to measure the 
alkaline phosphatase concentration in Units/mL.  
 
ALP activity (U/mL) = ( (amount of pNPP calculated from samples (µmol)/ volume of 
sample (mL) ) / reaction time (mins) 
 
Finally, from measurements obtained from proliferation studies for cell number, the values 
of alkaline phosphatase activity for each sample was measured per cell and per million of 
cells. 
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5.3.6. Measurements of osteogenic and differentiation expression using 
Osteocalcin levels: 
        18 labeled plates based on each group and timeline of 7 and 14 days with osteoblasts 
cultured during our study were used. At days 5 and 6 of cell culturing for the 7 days plates 
for all groups, the growth media was aspirated and replaced with differentiation media that 
was prepared in the lab according to protocol. This was also done on days 12 and 13 for 
the 14 days plates. Same as described previously for alkaline phosphatase, the supernatant 
from all 7 and 14 days plates were collected and placed into sterile test tubes that were 
labeled with condition and timeline. Using a human osteocalcin immunoassay (Quantikine 
ELISA) kit, osteocalcin levels in the samples were measured. The kit contains a 96-well 
microplate pre-coated with a monoclonal antibody specific for human osteocalcin. 
Supernatant samples and standards were pipetted into the wells. Any present osteocalcin in 
the samples would bind to the antibody.  
 
     At first, samples were centrifuged for 15 minutes with 1000 rpm to remove cellular 
particulates or debris. Following the manufacturer’s recommendation, all reagents used for 
this ELISA were brought to room temperature. A total volume of 500 mL of wash buffer 
was prepared by adding 20 mL of the wash buffer concentrate to 480 mL autoclaved 
deionized distilled water (1:25 dilution). The light sensitive color reagents A and B were 
mixed at equal volumes 15 minutes prior to use and kept protected from light. Exactly, 200 
µL of the resultants mixture was added per well. Then, 4 mL of Calibrator Diluent RD6-67 
was added to 16 mL of deionized water to make 20 mL of the diluted Diluent solution at a 
ratio of 1:5. To prepare the standards, osteocalcin standard crystals were we dissolved in 1 
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mL of deionized water to make 128 ng/mL. 300 µL of the diluted Calibrator Diluent was 
pipetted into 6 test tubes to produce a series of dilutions for the standards with 64 ng/mL 
being the highest, followed by 32, 16, 8, 4, 2 ng/mL. This was achieved by adding 300 µL 
of the standard into the first tube. All tubes were mixed well, and then transferred 300 µL 
of the mixture from the first tube into the second tube. The same procedure was repeated 
for the second tube to the third and onwards till the last tube of standard being 2 ng/mL 
with a volume of 600 µL.  
 
     The calibrator diluent solution (1:5), after treating it with same steps as that treated for 
supernatant samples, it served as the 0 ng/mL standard as instructed by the manufacturer. 
The zero standard served as the background and its optical density value was subtracted 
from readings measured using the microplate reader from all wells as instructed by the 
manufacturer.  
 
      Then, 200 µL of each standard concentration was pipetted into the pre-coated wells of 
the strips in duplicates in an ascending order according to a template we initially formatted 
to keep track of all wells and conditions. For supernatant samples, 100 µL of assay Diluent 
RD1-117 was added to each well. Then, 50 µL of each sample was added in each well in 
triplicates. The wells were then covered with an adhesive strip and the plate was incubated 
for two hours at room temperature on a horizontal orbital shaker set at 500 rpm. After 
incubation, the solution from each well was aspirated and wells were washed four times by 
adding 400 µL of wash buffer for each wash. After each wash, the buffer was aspirated 
from each well and then carefully blotted against a clean paper towel. Then, 200 µL of 
Human osteocalcin conjugate was added to each well, and then covered with an adhesive 
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strip and the antigen-antibody binding was allowed for 2 hours at room temperature on the 
horizontal orbital shaker. Aspiration and washing as explained in the previous step was 
done after incubation. Then, 200 µL of the substrate solution (A&B) was added to each 
well and incubated at room temperature for 30 minutes protected from light. After that, we 
added 50 µL of the Stop solution to each well and noticed the color of wells changed from 
blue to yellow. Finally, within 30 minutes of finishing the assay, the optical density values 
were measured using the microplate reader at a wavelength of 450 nm as suggested by the 
manufacturer. 
 
     Using the mean values obtained from the standards after subtracting the background, a 
curve was generated using Excel software to generate a log/log curve fit. Mean absorbance 
for each concentration (y-axis) was plotted against the concentration (x-axis). The best-fit 
line passing through the points was generated on a logarithmic graph. Using the formula of 
the trendline, the osteocalcin values in ng/mL for all test samples were calculated.  
(y= 0.0044 x1.3982 , R2 = 0. 99672). 
From measurements obtained from proliferation studies for cell number, the values of 
osteocalcin reflecting its levels for each sample was calculated to obtain the concentration 
measured per cell and per million of cells. 
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5.3.7. SEM examination: 
SEM examination of cells cultured and fixed on titanium and tissue culture treated 
coverslips: 
       The second passage pre-osteoblast cell culture from a single 225 cm2 flask was used 
for this experiment. A seeding cell concentration of 1x105 cells, were seeded onto 5 
titanium discs treated and 5 non-treated discs with ARGD, as well as 5 tissue culture 
treated coverslips (Thermanox) which are 15 mm in diameter each. The plastic coverslips 
were placed side to side in a 60 mm plastic Petri dish making sure they don’t overlap with 
each other. Cells were cultured for 16 hours in supplemented DMEM/F12 growth media in 
a standard CO2 incubator (37°C, 5% carbon dioxide, and saturated humidity). Then, plates 
containing the discs and coverslips were removed from the incubator into the lab safety 
cabinet and all media was aspirated from all plates. After that, all plates containing discs 
and coverslips were washed twice with 1X PBS solution. Immediately after, all plates were 
then transferred to the chemical fume hood to start the fixation process. For primary 
fixation of cells, all discs and coverslips surfaces were covered with an equal volume of 2 
mL of 2.5% (v/v) glutaraldehyde fixative solution for 2 hours at room temperature. Then, 
the solution was aspirated and all surfaces washed 5 times using deionized water. 
Secondary fixation was achieved using 1% (v/v) osmium tetroxide in double distilled 
water for 1 hour. After that, surfaces were washed 5 times with deionized water to remove 
traces of the osmium tetroxide. Finally, we performed a series of dehydration immersions 
for the samples using ascending concentrations of ethanol, 20, 50, 70, 90 and 100% each 
for 15 minutes. Lastly, surfaces were covered with hexamethyldisilazane (HMDS) for 15 
minutes at RT to achieve a full dehydration effect. After that, the specimens were mounted 
on aluminum stubs with carbon double-sided tape and sputter coated it with 
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gold/palladium in a sputter coater (Technics Hummer V sputter coater, USA) (Figure 5) at 
10mA for 30 seconds under vacuum, and then placed it in a desiccator overnight.  The 
specimens were examined under the FESEM (HITACHI SU6600, Japan) at an accelerated 
voltage of 5.0 kV and a working distance of 30 mm from the electron emission beam 
source (Figure 6). Cells were examined at 100x, 200x, 500x, 1000x, and 2500x and 
measured using Quartz PCI (Quartz Imaging Corporation, Vancouver BC) software. 
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Figure 5. Gold/palladium sputter coating machine (Technics Hummer V sputter coater). 
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Figure 6. FESEM (HITACHI SU6600) used to examine samples after gold/palladium 
sputter coating. 
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STASTICAL ANALYSIS 
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6. Statistical analysis 
 
Data analysis 
    Data are presented in means and standard deviations. Statistical significance is set at 
alpha p=0.05. The means and standard deviations (SD) of osteoblast cell attachment and 
proliferation percentages at 7 and 14 days were calculated, in addition to levels of 
osteogenic differentiation markers (Alkaline phosphatase and Osteocalcin) at the same 
timelines. All data was analyzed using a one-way ANOVA test to compare the means of 
all three the groups at each timeline, followed by Tukey’s post-hoc test to detect the 
statistical differences between the groups. The results were considered statistically 
significant at p<0.05. Statistical analysis was conducted using JMP pro version 11 
software. 
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7. Results 
 
7.1. Titanium surface wettability and contact angle following treatment 
with ARGD compared to non-treated titanium:  
       To ensure that the RGD technique was established, wettability and contact angles of 
droplets placed on titanium discs were measured.  
On the digital images captured using our camera and after downloading on our computer, 
the contact angles of the water droplets on both titanium surfaces, treated and non-treated 
with ARGD (3 discs per group) was measured using a conventional protractor. The contact 
angle is the angle at which the liquid-vapor interface meets the solid-liquid interface. The 
mean contact angle measured from the images of the droplet on titanium treated with 
ARGD was much smaller (3°) than the mean angle of the droplets measured  on the 
titanium without ARGD treatment (35°). The contact angle of the droplet on the non-
treated titanium surface is about 11.7 times larger than that measured on the ARGD treated 
disc. The very small contact angle of (3°) observed not only implies a very high degree of 
wettability and strong solid-liquid interaction for the titanium discs treated with ARGD, 
but also a wettability that is nearly perfect, as evident in the images below. (Figure 7) 
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A) 
	  
 
B) 
	  	  
Figure 7. Distilled water droplet experiment to evaluate wettability of the titanium surface by 
measuring the contact angle. A) Ti not treated with ARGD and B) Ti with ARGD treatment. 
(N=3 per group) 
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7.2. Osteoblast attachment and proliferation on the titanium surface 
treated by ARGD compared to non-treated titanium and plastic: 
7.2.1. Pre-osteoblast attachment efficiency: 
       Pre-osteoblast cells attachment on standard tissue culture Petri dish surfaces with a 
diameter of 60 mm was measured at different time intervals from the time of seeding. 
Theses time points were 1, 3, 6, 9, 12 and 16 hours. Two plates per timeline were 
measured and mean values were calculated. A hemocytometer was used to count the 
floating cells and that value was subtracted from the seeding cell concentration 1x105. 
Then, the percentage of attached cells was calculated by dividing the number of cells 
counted at each timeline by the total number of cells seeded. Attachment efficiency was 
calculated to establish a baseline on normal behavior of human osteoblasts in second 
passage of cell culture. Data are presented in the table below (Table 4). 
 
    Attachment efficiency was calculated to establish a baseline on normal behavior of 
human osteoblasts in second passage of cell culture. Based on those data, it is clear that all 
cells attach nearly entirely (98%) on tissue culture surfaces at 16 hours after cell seeding. It 
is also confirmed that no doubling occurred till this time point of 16 hours, as cell numbers 
higher that the seeding concentration of 1x105 have not been recorded. (Figure 8)
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Table 4. Data representing pre-osteoblasts cell attachment efficiency at different time 
intervals up to 16 hours cultured on tissue culture Petri dishes. (N=2 per timeline) 
 
Time after seeding Attachment efficiency (mean value) 
1 hour 63.7% 
3 hours 70.55% 
6 hours 76% 
9 hours 85% 
12 hours 91% 
16 hours 98% 
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Figure 8. Bar chart of pre-osteoblasts cell attachment efficiency on tissue culture plates up 
to 16 hours in culture. (N=2 per timeline) 
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    In a similar experiment, we compared attachment efficiency of the pre-osteoblasts on the 
three different surfaces used in ours study in triplicates, titanium treated and non-treated 
with ARGD and tissue culture treated plastic plates at 16 hours after cell seeding. Data 
presented in the graph below. (Figure 9) 
 
    By comparing the means of attachment efficiency percentages at 16 hours for all three 
groups, it was found that cell attachment on plastic and ARGD treated titanium were very 
consistent and having a slightly higher mean percentage of cell attachment compared to 
non ARGD treated titanium. However, there was no statistical significance in differences 
among the groups tested (p= 0.800). Data presented in the table below (Table 5):  
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Table 5. Data representing cells attachment efficiency at 16 hours on Ti with and without 
ARGD and tissue culture plates. (N=3 per group) 
 
Conditions Mean cell attachment % Std Error 
16 hours TCP 100 6.7717 
16 hours Ti w/ GD 97.487 5.5291 
16 hours Ti w/out GD 94.659 5.5291 
 
Ti w/GD: glow discharge treated titanium discs; Ti w/out GD: untreated titanium discs; 
TCP: tissue culture plates 
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Figure 9. Bar chart of pre-osteoblast attachment efficiency at 16 hours for all three tested 
groups (TCP, titanium with and without ARGD treatment). (N=3 per group) 
Ti w/GD: glow discharge treated titanium discs; Ti w/out GD: untreated titanium discs; 
TCP: tissue culture plates 
One-way ANOVA (p= 0.800) 
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7.2.2. Osteoblast proliferation: 
Cells from each plate in our experiment were fixed and subsequently stained using the 
crystal violet dye technique, as described in the materials and methods, at the time points 
16 hours, 7 days and 14 days. As mentioned previously, day 7 is the time point where 
maximal cell confluence is reached as was determined from our initial pilot studies. Day 
14 is the day when natural cell growth declines. Using the optical density values measured 
from the spectrophotometer, values were converted to cell number. The ratio of cellular 
crystal violet stain to cell number has been determined from the known seeding cell 
numbers in plates and measuring the corresponding dye stain from those plates three times 
using the same and different seeding numbers of cells. The ratio has been consistent and 
reproducible for all those measurements and therefore, it could be used to convert the 
optical density dye data to cell numbers with confidence.  
Then, cell numbers measured at each timeline from each group were divided by the 
average cell number of the positive control (plastic group) mean of the corresponding 
timeline in order to determine the proliferation rate (cell % to control).  This conversion 
allowed a direct comparison of the cells grown on titanium to those cells grown on the 
plastic control group at each time point.  
Mean cell percentages of cell proliferation for the ARGD group at 7 days was the 
highest (167.966%) among the three groups. The difference in means for cell proliferation 
percentage measurements between the three groups (ARGD, no ARGD and TCP) at 7 days 
was statistically significant (p=0.0022). When testing all possible pairs interactions for 
each timeline, at 7 days (ARGD vs. TCP, ARGD vs. no ARGD, no ARGD vs. TCP) the 
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differences in means were statistically significant between (ARGD vs. no ARGD, and 
ARGD vs. TCP) (p=0.0018, and p=0.0286), respectively. However, there was no statistical 
difference between TCP and no ARGD groups at day 7 (p=0.0946).  
     (Figure 10) 
 
  At day 14, the highest mean of cell proliferation percentage was also highest for the Ti 
ARGD group (261.744%). The difference in cell proliferation percentage means between 
groups at 14 days was statistically significant (p=0.0002). When testing all possible pairs 
interactions for the different groups at day14 (RGD vs. TCP, ARGD vs. no ARGD, no 
ARGD vs. TCP) the differences in means were statistically significant between (ARGD vs. 
TCP, p= 0.0003) and (no ARGD vs. TCP, p=0.0007) but not between (ARGD and no 
ARGD, p=0.4694). (Figure 11) 
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Figure 10. Bar chart showing osteoblast cells proliferation percentages at 7 days of cell 
culture compared to the plastic control group. (N=3 per group) 
Ti w/GD: glow discharge treated titanium discs; Ti w/out GD: untreated titanium discs; 
TCP: tissue culture plates 
Tukey’s post hoc test: (TCP vs. Ti w/GD p= 0.0018), (Ti w/GD vs. Ti w/out GD p= 
0.0286), (TCP vs. Ti w/out GD p= 0.0946) 	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  Figure 11. Bar chart showing osteoblast cells proliferation percentages at 14 days of cell 
culture compared to the plastic control group. (N=3 per group) 
Ti w/GD: glow discharge treated titanium discs; Ti w/out GD: untreated titanium discs; TCP: 
tissue culture plates 
Tukey’s post hoc test: (TCP vs. Ti w/GD p= 0.0003), (Ti w/GD vs. Ti w/out GD p= 0.4694), 
(TCP vs. Ti w/out GD p= 0.0007) 
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7.3. Osteogenic expression of osteoblasts on the titanium surface 
treated by ARGD compared to non-treated titanium and plastic 
7.3.1. Detection of tissue non-specific alkaline phosphatase activity of 
differentiated osteoblasts: 
Alkaline phosphatase activity, which is a measure of osteogenic differentiation, was 
measured using a colorimetric endpoint assay Alkaline Phosphatase “Colorimetric” Assay 
Kit (Abcam, Cambridge MA) at 7 and 14 days in duplicates. Osteoblasts secrete alkaline 
phosphatase during early differentiation and it is necessary to permit bone cells to start the 
mineralization phase. Samples of supernatants from cell culture were used to test for the 
enzymatic activity within them. The mean ALP activity measured was highest for the 7 
days tissue culture plates (471090 units/mL per 106 cells), compared to titanium discs with 
and without ARGD treatment. There was a statistical significant difference in alkaline 
phosphatase activity levels between TCP and ARGD groups (p=0.0014) and between TCP 
and no ARGD groups (p=0.0020). However, there was no significant difference between 
titanium groups treated and not treated with ARGD (p=0.8962). (Figure 12) 
 
  At 14 days, the mean value was highest for the tissue culture plates (301807 units/mL 
per 106 cells) compared to titanium discs with and without ARGD treatment. There was a 
statistical significant difference in alkaline phosphatase activity between TCP and ARGD 
groups (p=0.0051) and between TCP and no ARGD groups (p=0.0078). There was no 
significant difference between titanium groups treated and not treated with ARGD 
(p=0.9042). (Figure 13) 
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Figure 12. Bar chart showing alkaline phosphatase (EC 3.1.3.1) activity at 7 days from 
osteoblasts cell culture. (N=3 per group) 
Ti w/GD: glow discharge treated titanium discs; Ti w/out GD: untreated titanium discs; 
TCP: tissue culture plates 
Tukey’s post hoc test: (TCP vs. Ti w/GD p= 0.0014), (Ti w/GD vs. Ti w/out GD p= 
0.8962), (TCP vs. Ti w/out GD p= 0.0020) 
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Figure 13. Bar chart showing alkaline phosphatase (EC 3.1.3.1) activity at 14 days from 
osteoblasts cell culture. (N=3 per group) 
Ti w/GD: glow discharge treated titanium discs; Ti w/out GD: untreated titanium discs; 
TCP: tissue culture plates 
Tukey’s post hoc test: (TCP vs. Ti w/GD p= 0.0051), (Ti w/GD vs. Ti w/out GD p= 
0.9042), (TCP vs. Ti w/out GD p= 0.0078) 	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7.3.2. Quantification of human osteocalcin concentrations in tissue 
culture supernatants: 
        Osteocalcin was measured from the supernatant culture medium collected from all 7 
and 14 days plates using Human Osteocalcin Quantikine ELISA Kit (R&D, Minneapolis, 
MN). Data were expressed as total nanograms/mL of human OCN per 106 cells from 
supernatant solutions at 7 and 14 days. Similar to the observation of the alkaline 
phosphatase enzymatic activity, at 7 days the mean level of osteocalcin was highest for 
tissue culture plates (99.2973 ng/mL per 106 cells) compared to titanium discs with and 
without ARGD treatment. There was a statistical significant difference in means of 
osteocalcin levels between TCP and ARGD groups and between TCP and no ARGD 
groups (p=0.0033, p=0.0438) respectively. There was no statistical difference between the 
ARGD treated and non-treated titanium groups (p=0.5164). (Figure 14) 
 
      At day 14, tissue culture plates had the highest measured mean of osteocalcin levels 
(21.1161 ng/mL per 106 cells) compared to titanium discs with and without ARGD 
treatment. There was a statistical significance in osteocalcin levels between TCP and 
ARGD groups (p<0.0001) and between TCP and no ARGD groups (p=0.0001). However, 
there was no statistical difference between the ARGD treated and non-treated titanium 
groups (p=0.2886). (Figure 15) 
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Figure 14. Bar chart showing osteocalcin levels at 7 days from osteoblast cell culture. (N=3 
per group) 
Ti w/GD: glow discharge treated titanium discs; Ti w/out GD: untreated titanium discs; TCP: 
tissue culture plates 
Tukey’s post hoc test: (TCP vs. Ti w/GD p= 0.0033), (Ti w/GD vs. Ti w/out GD p= 0.5164), 
(TCP vs. Ti w/out GD p= 0.0438) 
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Figure 15. Bar chart showing osteocalcin levels at 14 days from osteoblast cell culture. 
(N=3 per group) 
Ti w/GD: glow discharge treated titanium discs; Ti w/out GD: untreated titanium discs; 
TCP: tissue culture plates 
Tukey’s post hoc test: (TCP vs. Ti w/GD p<0.0001), (Ti w/GD vs. Ti w/out GD p= 
0.02886), (TCP vs. Ti w/out GD p= 0.0001) 
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7.4. SEM analysis of cells cultured on titanium discs treated and non-
treated with RGD and plastic culture slips: 
          SEM qualitative analysis at 16 hours: 
Osteoblast cells were cultured on the titanium discs treated and non-treated with 
ARGD as well as culture treated slips (Thermanox) in plastic Petri plates for 16 hours. All 
cells were then fixed according to SEM fixation protocol followed by sputter coating with 
gold/palladium. It was observed that cells cultured on Titanium discs treated with ARGD 
had a high cell density and better attachment quality by assessing the actin filaments and 
cytoplasmic extensions (filopodia) of the attached cells. Cells cultured on tissue culture 
treated plastic slips also showed a high density of attached cells, as well as more actin 
filaments and cell cytoplasmic extensions compared to cells cultured on titanium discs not 
treated with ARGD. (Figures 16-20) 
 
It was observed that cells on both tissue culture slips and titanium with ARGD 
treatment had a more homogenous spread of cells on the surface in addition to better cell to 
cell contact compared to cells cultured on non-treated titanium discs. (Figures 16-19) Cells 
on the culture treated slips and ARGD treated titanium had a polygonal morphology. 
(Figure 18,19) On the other hand, cells on non-treated titanium discs was observed to have 
an elongated spindle shape with less actin filaments and cell extensions. (Figure 21) Also, 
there was a tendency to form isolated cell clusters rather than having a homogenous cell 
spreading on the entire surface of the non-treated titanium. (Figure 22)
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Figure 16. Scanning electron micrographs of human pre-osteoblast cells cultured for 16 
hours on the different experiment discs at 100x magnification. A) Ti without GD 
treatment, B) Ti with GD treatment, and C) tissue culture treated slips. 
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Figure 17. Scanning electron micrographs of human pre-osteoblast cells cultured for 16 
hours on the different experiment discs at 200x magnification. A) Ti without GD 
treatment, B) Ti with GD treatment, and C) tissue culture treated slips. 	  
 
	   76	  
 
 
Figure 18. Scanning electron micrographs of human osteoblast cells cultured for 16 hours 
on the different experiment discs at 500x magnification. A,B,C) Ti without GD treatment, 
arrows pointing at the spindle shape morphology of cells on this surface D,E,F) Ti with 
GD treatment, arrows pointing at the polygonal cell morphology with multiple cytoplasmic 
extensions and G,H,I) Plastic tissue culture treated slips, arrows pointing at the polygonal 
cell morphology with multiple cytoplasmic extensions. 
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Figure 19. Scanning electron micrographs of human pre-osteoblast cells cultured for 16 
hours on the different experiment discs at 1000x magnification. A) Ti without GD 
treatment, B) Ti with GD treatment, and C) tissue culture treated slips. 
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Figure 20. Scanning electron micrographs of human pre-osteoblast cells cultured for 16 
hours on the different experiment discs at 2500x magnification. A) Ti without GD 
treatment, B) Ti with GD treatment, and C) tissue culture treated slips. 
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Figure 21. Scanning electron micrographs of human pre-osteoblast cells cultured for 16 
hours at 250x magnification on Ti discs without GD treatment showing the unique 
morphology of the cells appearing elongated and spindle-like. 
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Figure 22. Scanning electron micrographs of human pre-osteoblast cells cultured for 16 
hours at 250x magnification showing the phenomenon of islands of cell clustering 
observed only on Ti discs without GD treatment.	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8. Discussion 
 
     Dental implants are the treatment of choice and standard of care for patients with 
missing teeth. The fact that this treatment option has a big price tag, all efforts have been 
made to ensure its survival and longevity. The key to dental implant success is the 
formation and maintenance of OI [10]. One way to enhance OI is through implant surface 
modification through sand blasting, acid etching, and plasma of Argon glow discharge [81-
83]. 
 
ARGD is a surface modification and sterilization technique with the aim to modify and 
improve the thickness of the TiO2 layer. As a result, there is an increase in implant surface 
hydrophilicity, and osteoblast cell attachment and proliferation. ARGD surface treatment 
has been previously investigated by many researchers who had demonstrated promising 
outcomes. Guastaldi et al conducted a study in beagle dogs, and compared the effect of 
implant surfaces treated with ARGD versus non-washed resorbable blasting media on OI 
[76]. They noted that implant surfaces treated with ARGD had more bone area fraction 
occupancy and higher level for torque compared to control, resulting in improved 
biomechanical fixation and bone formation. However, all of the previous studies have used 
non-human (animal) cell lines to study ARGD. Up to date, there is no report in the 
literature on how ARGD surface treatment of titanium implants affects the attachment, 
proliferation and osteogenic differentiation of normal human osteoblast cells. To answer 
and further investigate the benefit of ARGD, this study was conducted. 
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 To better understand the advantage of implementing ARGD in dental implants 
manufacturing, human osteoblast cell behavior (attachment, proliferation and 
differentiation) and surface wettability of Ti treated with ARGD had to be further 
investigated. The first part of this study was designed to investigate human osteoblast 
attachment and proliferation on Ti discs treated with ARGD and compare it to tissue 
culture plates and non-treated Ti discs. At the same time, Ti surface wettability and contact 
angle following treatment with ARGD were evaluated. The results of our study showed 
increased cell proliferation rates of human osteoblasts cultured on titanium discs, treated 
with ARGD compared to non-treated titanium and TCP groups. This could be attributed to 
the fact that ARGD treatment, which includes sterilization of the surface, can increase the 
surface energy as well as the thickness of the Titanium dioxide layer and increase surface 
wettability. This result has been reported before by Kawahara et al [66]. Using Auger 
electron spectroscopy, and Fourier transform infrared-reflection absorption spectroscopy; it 
was found that ARGD-treated Ti surfaces exhibited a cleaner surface as compared to 
sputtered or autoclaved titanium surfaces. In addition, the existing oxide layer of ARGD-
treated Ti specimens enhanced calcium and/or phosphate affinity due to an increase in 
elemental interactions and formation of amorphous calcium phosphate compounds. This is 
a phenomena favored for improved dental implant OI [84, 85]. 
 
       In a clinical setting, and at the time of implant placement, dental implants are being 
exposed to organic impurities and contaminants present within the surrounding 
environment, which may coat the exposed implant. The presence of surface treatment 
technology with the ability to treat dental implant surfaces can facilitate osteoblasts’ 
adherence to the surface and favor cell attachment required for normal healing. Ultra violet 
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radiation, as an alternative surface treatment, has been studied in the past and was shown to 
effectively decontaminate the surface treated and eradicate the unwanted carbon layer [86]. 
However, it was rendered an inconvenient method of sterilization for clinical use since it 
requires 24-48 hours of treatment to be effective. Thus, sterilization of dental implant Ti 
surface using ARGD may offer a quick and easy option for an improved outcome. In such 
a scenario, the clinician and just before placing the implant in the prepared osteotomy, will 
treat the implant surface with ARGD and insert the implant right after. This will assure 
better surface cleanliness and hinder the attachment of bacteria and other contaminants to 
dental implants that might negatively affect the healing process.  
 
      The increase in surface energy of Ti discs treated with ARGD, proven by the increased 
hydrophilicity of the surface and decreased contact angle from the current data, may 
enhance the attachment of hydrophilic osteoblasts and spread on the surface. This will 
eventually translate into improved healing and better outcome. Based on our results, the 
increased wettability and surface energy of treated titanium can be explained by the 
physical and chemical change in Ti surface exposed to excited gas molecules (in this case 
it is the Argon gas). As a result, a thin layer of exposed amine groups is formed on the 
surface, which favors the attachment of extracellular matrix proteins (such as fibronectin 
and cellular surface proteins integrins) binding to the focal adhesion complexes, which in 
turn initiates the cellular bio-attachment response [87]. All these findings are in 
concordance with previously published studies, which showed an increase in attachment 
and proliferation of other cell lines cultured on titanium treated with plasma glow 
discharge, as the osteoblast-like MC3T3 cells [61]. 
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 The attachment and proliferation of osteoblasts on Ti-surfaces treated with ARGD does 
not ensure function. Thus, the next step in this research was to confirm that the attached 
human osteoblasts maintained their osteogenic expression abilities. The results of our 
study demonstrated that there is an expression of both early differentiation biomarker 
specifically alkaline phosphatase and late differentiation biomarker osteocalcin after 7 and 
14 days of cell culture. While alkaline phosphatase is an important biomarker for 
mineralization, it is non-tissue specific and could be secreted by cells other than bone. 
Osteocalcin on the other hand, is a key marker of osteoblastic cells phenotype and 
indicates the capability of biomineralization [62, 88].  
 
The combination of both markers’ levels is considered a more accurate method to 
assess osteoblast functionality. Levels of both differentiation biomarkers expressed by 
osteoblast cells were evident in all groups at day 7 of cell culture, and then decreased at 14 
days. However, there was no statistical difference between levels measured of these 
biomarkers in both titanium groups, but levels were lower compared to the tissue culture 
treated polystyrene group. This might indicate that ARGD surface treatment of Ti discs 
lacks a boosting effect on differentiation of osteoblast cells cultured on its surface. In 
addition, there may be a prolonged proliferation phase of human osteoblasts in culture, 
which caused delays the differentiation of these cells. Another possibility is that the effect 
of ARGD surface treatment is evident and most profound in the early days of cell culture 
and this effect is gradually minimized as time is elapsed. This is similar to what Rapuano 
et al. reported in 2013 when culturing MC3T3 cells on ARGD pretreated Ti discs and 
reported an increase in Ca:P mineral content in the cell culture in the first 1-2 weeks 
compared to the heat pretreated group, which showed the increase at 2-4 weeks of culture. 
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At the same time, there was a dramatic increase in alkaline phosphatase activity and 
osteocalcin levels from cell cultures on the tissue culture treated polystyrene group [63]. 
This could be attributed to the fact that tissue culture treated surfaces possess unique 
properties making it an optimal surface for human osteoblast cells to differentiate as 
evident by the marked increased values of the differentiation biomarkers (namely alkaline 
phosphatase and osteocalcin) at 7 and 14 days. In addition, the differences in biomarkers 
levels between TCP and titanium groups (statistically significant at both timelines) could 
be due to the titanium surface exhibiting an inhibiting or delaying effect on cells to 
differentiate compared to those grown on tissue culture polystyrene surfaces, however this 
has not been investigated before. Other possibilities behind the lower differentiation 
biomarkers’ values measured in the titanium groups include a possible demand by 
osteoblast cells grown on titanium for different differentiation media contents and nutrients 
or different concentrations of certain ingredients as vitamin D3 compared to cells grown on 
the plastic polystyrene surface as reported before [89]. The exact effect of polystyrene on 
human osteoblast cells and the role of culture media on cell differentiation can be later 
investigated.  
 
In the same experiment, there was a trend in alkaline phosphatase activity and 
osteocalcin levels decreasing from day 7 to day 14 of human osteoblast cell culture. One 
explanation could be the lack of necessary nutrients for osteoblasts, in addition to 
insufficient incubation time in differentiation media during the period from day 7 up to day 
14 as part of the experiment design. Instead, for the 14 day plates, the differentiation media 
replaced the growth media for osteoblasts cultures starting day 11 (only 3 days) prior to 
expected date of aspiration and collection of supernatant for biomarkers measuring step. 
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This finding is similar to what has been reported by Siggelkow et al. in 2002, where they 
observed a peak of alkaline phosphatase activity, osteocalcin levels, and osteogenic gene 
expressions at day 7 of human osteosarcoma cell culture (HOS 58) and a decrease 
thereafter. In that study, cells were cultured for 28 days and the decrease in alkaline 
phosphatase activity was noted to be lower by 62% after day 7 of cell culture. In that study, 
there was a parallel decrease in alkaline phosphatase gene expression following cell 
confluence at day 7, which supports their findings. In addition, it was suggested that the 
decrease in alkaline phosphatase is linked to prolonged cell culture with Vit D3 [89]. In 
another study by He Liu et al. in 2005, it was reported that cultured dental pulp stem cells 
(DPSC) had increased differentiation biomarker alkaline phosphatase levels at the peak of 
cell confluence, followed by a decrease thereafter.[90] It was noted that down regulation of 
matrix extracellular phosphoglycoprotein gene expression (MEPE) is linked to the 
decrease in alkaline phosphatase activity and level drop.  
 
It has been long known that various cell lines could behave differently even if cultured 
in the same conditions. As a result and the fact that our study is the first to use human 
osteoblasts, it could be difficult to compare our results with previous studies that used 
cancer, non-human, or other human cell lines, which also measured differentiation 
biomarkers. Rapuano et al. reported on the MC3T3-E1 subclone 4 cell line used in a 
similar experiment design to our current study, and reported that this particular cell line 
had a higher potential for osteoblastic differentiation compared to other parentral cell lines 
[61, 91]. Collagen Type I, osteocalcin, and ECM gene markers were all amplified for this 
cell line when cultured on ARGD pretreated titanium alloy discs and it was believed to be 
due to continuous osteoprogentior cell proliferation. 
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To further investigate the human osteoblasts quality and function, SEM qualitative 
analysis of cultured cells on titanium discs treated with ARGD was performed and 
compared to control at 16 hours. SEM images of osteoblast cells cultured on both titanium 
discs treated with ARGD and plastic tissue culture treated slips showed the highest cell 
density per surface area. The attachment quality and cell spread patterns on the surface was 
significantly homogenous for both surfaces. In addition, individual cells showed multiple 
peripheral dendritic extensions, indicating excellent cell-to-cell contact. In one way, we 
can attribute this finding to increased surface energy and wettability of the ARGD treated 
surfaces of titanium discs and irradiation effect treatment on plastic tissue culture surfaces. 
High surface energy and increased wettability results in a decreased contact angle, 
compared to low energy surfaces. This phenomenon in theory may enhance cells’ 
attachment to treated disc surfaces followed by proliferation due to the increased 
attachment efficiency. It was also evident from the SEM images the polygonal morphology 
of the attached cells on the ARGD treated titanium discs and plastic coverslips. The 
associated cellular cytoplasmic extensions contain organized actin filaments, which are 
known to improve the cells’ surface bioattachment quality. Huang et al. in 2011 reported 
similar SEM imaging findings when cultured MG-63 cells on titanium treated surfaces 
with ARGD [72]. This was also reported by Han et al. in 2011 when cultured MC3T3-E1 
pre-osteoblast mouse cells and human mesenchymal stem cells on titanium discs pretreated 
with Helium plasma glow discharge [92]. Upon examination of cells’ attachment and 
morphology on the treated surfaces, using a fluorescence microscope, it was observed that 
cells in the treated group exhibited highly organized actin filaments and cytoskeleton 
structures compared to control. Similarly in our study, human osteoblasts cultured on 
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titanium surfaces not treated with ARGD, have shown an overall less dense cellular 
attachment and spread on the surface in addition to its less than ideal cell morphology. 
 
Cell morphology examination of the attached osteoblast cells to untreated surfaces, 
compared to those attached to ARGD-treated surfaces, were shown to have a more spindle 
and elongated shape with less of a spread on the surface. This spindle shaped morphology 
of cells on the untreated titanium surfaces was similar to the observation reported by 
Huang et al [72]. The frequency of cellular dendritic extensions and network of filaments 
was much less in number compared to cells cultured on ARGD-treated titanium and plastic 
slips surfaces. This is somehow similar to findings reported by Han et al. where cells in the 
ARGD-untreated titanium group showed a round morphology with underdeveloped 
cytoskeleton [92]. Another phenomena that was only observed upon examining samples of 
cells cultured on ARGD-untreated titanium discs, was the tendency of cells to form 
isolated islands of cell clusters in various sites of the surface rather than a homogenous 
spread. This could be due to cells’ affinity to attach to other cells which are hydrophilic, 
rather than to a more hydrophobic surface with lower wettability and surface energy 
namely the ARGD-untreated surface. This phenomenon would theoretically result in a less 
cohesive, and less stable osseointegrated bone on the implant surface in a clinical setting.  
 
This current study is unique and is the first to use human osteoblast cells which mimics 
the actual cell behavior in clinical settings. The results of this study contributes to the 
current literature focusing on dental implants’ success and further investigates the 
possibility of incorporating ARGD as a potential and promising implant surface treatment 
and coating. The data provided, with further supporting studies, could provide clinicians 
	   90	  
with the option to pretreat any dental implant chair side immediately prior to implant 
surgical placement. This may result in a better longevity and success and ultimately better 
patient satisfaction.   
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9. Conclusion 
 
The results of this study indicated that ARGD surface treatment of titanium implants 
significantly enhanced cell proliferation of human osteoblast cells. There was no 
significant difference in cell attachment at 16 hours on the three different experimental 
surfaces. There was no significant difference in osteogenic differentiation of cells cultured 
on titanium with and without ARGD treatment. However, a trend showing a prolonged 
proliferation phase for cells cultured on ARGD treated Titanium was observed. Wettability 
of the titanium surface treated with ARGD was increased compared to the non-treated 
titanium surface. This resulted in a favorable morphology of the cells attached, and a 
homogenous spread of these cells on the treated titanium surface and thus enhancing its 
proliferation. Future studies are required to confirm our results and the observed benefits 
of RFGD treated titanium, in more animal studies and specifically in randomized human 
clinical trials. 
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CLINICAL CONSIDERATIONS 
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10. Clinical considerations 
 
The results of our study suggest a potential clinical benefit for treating titanium dental 
implants with ARGD before surgically placing it in the patient’s alveolar bone. This is 
evident from the increased proliferation of osteoblast cells on treated titanium surfaces. 
Also, the possible prolonged proliferation phase of osteoblast cells may translate clinically 
to an improved bone to implant contact and osseointegration, which will result in a better 
healing outcome and longer implant survival. Future implementation of ARGD in dental 
implants manufacturing may help to improve implants’ success and long-term survival, 
and decrease its failure rate. 
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